An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
UPMC Hillman Cancer Center would like to welcome Melanie Potiaumpai, PhD, MPH, effective August 1, 2023. Dr. Potiaumpai is joining as assistant professor in the Department of Medicine, Division of Hematology/Oncology at the University of Pittsburgh and a member of…
UPMC Hillman Cancer Center would like to welcome Anthony (Tony) R. Cillo, PhD, effective August 1, 2023. Dr. Cillo is an assistant professor in the Department of Immunology at the University of Pittsburgh and a member of the Tumor Microenvironment…
Saiful Huq, PhD, FAAPM, FInstP, Director of the Medical Physics Division at UPMC Hillman Cancer Center and Professor of Radiation Oncology at the University of Pittsburgh School of Medicine, received the William D. Coolidge Gold Medal Award from the American…
Benjamin A. Nacev, MD, PhD, assistant professor of medicine in the Division of Hematology/Oncology, has been named a Damon Runyon Clinical Investigator by the Damon Runyon Cancer Research Foundation. With his mentor, Jeremy Rich, MD, Dr. Nacev will receive $600,000…
UPMC Hillman Cancer Center is pleased to welcome Yvonne Mowery, MD, PhD, DABR, effective June 1, 2023. Dr. Mowery is associate professor in the Department of Radiation Oncology at the University of Pittsburgh and will see patients in the outpatient clinic…
Friday, June 2 Posters Divya Natesan “Differences in real-world pembrolizumab dosing patterns (every 3 weeks versus every 6 weeks) across a large cancer center network” 8 to 11 a.m. Hall A | Abstract 2592 | Board 434 Jingxiao Jin, MD…
Researchers have known that microorganisms in the gut can impact the effectiveness of immunogenic chemotherapies for cancer patients. When studies showed that the same could be true for immune checkpoint inhibitors, it opened the possibility for better treatment options for…
UPMC Hillman Cancer Center is pleased to announce Patricia L. Opresko, PhD, as the Dr. Bernard F. Fisher Chair for Breast Cancer Discovery Science, a newly formed chair being launched this year. Dr. Opresko was nominated for this appointment because…
Head and neck cancer accounts for approximately 4% of cancer cases in the U.S. — affecting more than 60,000 people each year. The majority of those diagnosed are over the age of 50, but a rising rate of HPV-associated head…
Friday, April 14 Sessions Nadine Hempel, PhD “Oxidative stress adaptations during metastasis: Focus on antioxidant enzyme function and regulation” 3 to 4:30 p.m. Tangerine Ballroom 3 & 4 Lan G. Coffman, MD, PhD “Studying the impact of the aging stromal…
